Price and availability of Novo, Lilly’s weight loss drug

list Here.

Here are the launch and pricing details for currently approved weight loss drugs:

APPROVALS AND AVAILABILITY

Eli Lilly

Foundayo (orforglipron): Approved in the United States in 2026 as a once-daily oral GLP-1 therapy for weight loss. Available in the US starting April 6 through the LillyDirect platform, with a wider rollout for retail pharmacies and telehealth providers to follow.

Zepbound: Approved in the US in 2023. The drug, chemically known as tirzepatide, is also available in Canada, Australia, Japan, China, India, the UK and the European Union.

Novo Nordisk

Wegovy pill (oral semaglutide): Approved in December 2025 and launched in the US in January 2026.

Wegovy injection: Approved in the US in 2021 and then launched in more than 15 countries in Europe, North America and Asia.

price

Eli Lilly

Foundayo: Self-pay pricing starts at $149 per month for the lowest dose via the LillyDirect program. Most patients are expected to pay about $349 per month, with refill incentives reducing the cost to as little as $299.

Zepbound: Available in six doses. US list prices range from $499 to $1,086.37, but the amount patients pay largely depends on the prescription drug insurance plan. Those with commercial drug insurance may be eligible to pay as little as $25 for a one- or three-month supply of ⁠Zepbound.

Lilly US pricing for Zepbound starts at $299 a month for a 2.5 mg dose, $399 for 5 mg and $449 for 7.5 mg and higher doses under the “Pay Independent Travel Program”.

The UK list price, excluding tax, is £133 for a four-week supply of 2.5mg pre-filled pens, £180 for 5mg, £255 for 7.5mg and 10mg doses, and £330 for 12.5mg and 15mg, according to NICE, the UK medicines watchdog.

Novo Nordisk

Wegovy pills: Patients with commercial insurance pay $25 per month, while self-pay prices start at $149 per month for 1.5 mg and 4 mg until August 31, 2026. After that, 4 mg is $199 per month. The 9 mg and 25 mg doses cost $299 per month.

Wegovy Injection: US List price $1,349.02 per package. Commercial insurance can reduce the cost to $25 per month for the pen, while cash-paying customers pay $349 per month for doses ranging from 0.25 mg to 2.4 mg.

The UK list price is £175.80 per pack for the 2.4 mg dose, £124.53 for the 1.7 mg, and £73.25 for the 0.25 mg, 0.5 mg and 1.0 mg doses, excluding tax, according to NICE. Each pack contains one pen that delivers four doses.

($1 = 0.7507 pounds)

Our Standards: The Thomson Reuters Trust Principles.open a new tab